title: [Pseudophakic inferior retinal detachment or detachment with inferior breaks: clinical outcome and recurrences after primary vitrectomy-gas].
abstract: BACKGROUND
  This study aims to evaluate the outcome of primary vitrectomy/gas for pseudophakic retinal detachment (RD) located inferiorly or associated to inferior breaks.
  
  
  METHODS
  We performed a retrospective, non-randomised study comprising 18 pseudophakic RD eyes with inferior RD (group A) and 19 pseudophakic RD eyes with inferior breaks (group B) treated with primary vitrectomy and gas tamponade (SF (6) 20 %). Pre- and postoperative characteristics were analysed, focusing on RD recurrences.
  
  
  RESULTS
  In group A, RD recurred in 2/18 eyes (11 %) and was associated to proliferative vitreoretinopathy (PVR) both at first intervention and on recurrence. In group B, RD recurred in 4/19 eyes (21 %). One eye presented PVR at first intervention and all at re-intervention. Anatomic reapplication was achieved after second vitrectomy/gas in 2/4 eyes of group B, whereas long-term silicon oil tamponade was needed in 2 eyes of each group.
  
  
  CONCLUSIONS
  This series shows a high success rate of primary vitrectomy/gas in pseudophakic RD patients with inferior RD or detachment associated to inferior breaks. Recurrences after vitrectomy are most often related to the presence of PVR.
authors.affiliation: Clinique d'Ophtalmologie, Hôpitaux Universitaires de Genève, Suisse.
authors.forename: N P
authors.initials: NP
authors.lastname: Dang Burgener
authors.forename: I K
authors.initials: IK
authors.lastname: Petropoulos
authors.forename: A N
authors.initials: AN
authors.lastname: Stangos
authors.forename: C J
authors.initials: CJ
authors.lastname: Pournaras
mesh_terms: D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D019591:Pseudophakia / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D012160:Retina / Q000187:drug effects / Q000293:injuries* / Q000601:surgery*; D012163:Retinal Detachment / Q000175:diagnosis / Q000628:therapy*; D012189:Retrospective Studies; D055502:Secondary Prevention; D013459:Sulfur Hexafluoride / Q000008:administration & dosage*; D016896:Treatment Outcome; D014821:Vitrectomy
chemical_list: D013459:Sulfur Hexafluoride